Interobserver variability in interim PET assessment in Hodgkin lymphoma—reasons and solutions
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0283694 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Thomas W Georgi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany. Hauptthemen laut MEDLINE: Hodgkin Disease, Lymphoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Interim PET (iPET) assessment is important for response adaptation in Hodgkin lymphoma (HL). The current standard for iPET assessment is the Deauville score (DS). The aim of our study was to evaluate the causes of interobserver variability in assigning the DS for iPET in HL patients and to make suggestions for improvement.
Methods
All evaluable iPET scans from the RAPID study were re-read by two nuclear physicians, blinded to the results and patient outcomes in the RAPID trial. The iPET scans were assessed visually according to the DS and, thereafter, quantified using the qPET method. All discrepancies of more than one DS level were re-evaluated by both readers to find the reason for the discordant result.
Results
In 249/441 iPET scans (56%) a concordant visual DS result was achieved. A “minor discrepancy” of one DS level occurred in 144 scans (33%) and a “major discrepancy” of more than one DS level in 48 scans (11%). The main causes for major discrepancies were 1) different interpretation of PET-positive lymph nodes—malignant vs. inflammatory; 2) lesions missed by one reader and 3) different assessment of lesions in activated brown fat tissue. In 51% of the minor discrepancy scans with residual lymphoma uptake, additional quantification resulted in a concordant quantitative DS result.
Conclusion
Discordant visual DS assessment occurred in 44% of all iPET scans. The main reason for major discrepancies was the different interpretation of PET positive lymph nodes as malignant or inflammatory. Disagreements in evaluation of the hottest residual lymphoma lesion can be solved by the use of semi-quantitative assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany.
- Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
- King's College London and Guy's & St Thomas' PET Centre, School of Biomedical Engineering and Imaging Sciences, Kings College London, London, United Kingdom.
- University of Manchester and Christie National Health Service Foundation Trust, Manchester, United Kingdom.
ORCID-Profile: Thomas W Georgi
Zitieren
APA
Georgi, T. W., Kurch, L., Hasenclever, D., Warbey, V. S., Pike, L., Radford, J., Sabri, O., Kluge, R., & Barrington, S. F. (2023). Interobserver variability in interim PET assessment in Hodgkin lymphoma—reasons and solutions. PLOS ONE. https://doi.org/10.1371/journal.pone.0283694
Vancouver
Georgi TW, Kurch L, Hasenclever D, Warbey VS, Pike L, Radford J, et al. Interobserver variability in interim PET assessment in Hodgkin lymphoma—reasons and solutions. PLOS ONE. 2023. doi:10.1371/journal.pone.0283694
BibTeX
@article{Georgi2023,
author = {Georgi, Thomas W and Kurch, Lars and Hasenclever, Dirk and Warbey, Victoria S and Pike, Lucy and Radford, John and Sabri, Osama and Kluge, Regine and Barrington, Sally F},
title = {Interobserver variability in interim PET assessment in Hodgkin lymphoma—reasons and solutions},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0283694}
}
EUVIMED